Incyte Corp. (INCY)
115.24
-0.63
(-0.54%)
USD |
NASDAQ |
Nov 20, 15:09
Incyte 30-Day Average Daily Volume : 1.727M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 1.727M |
| November 18, 2026 | 1.752M |
| November 17, 2026 | 1.754M |
| November 16, 2026 | 1.761M |
| November 13, 2026 | 1.776M |
| November 12, 2026 | 1.817M |
| November 11, 2026 | 1.862M |
| November 10, 2026 | 1.876M |
| November 09, 2026 | 1.874M |
| November 06, 2026 | 1.883M |
| November 05, 2026 | 1.874M |
| November 04, 2026 | 1.867M |
| November 03, 2026 | 1.847M |
| November 02, 2026 | 1.830M |
| October 30, 2026 | 1.814M |
| October 29, 2026 | 1.842M |
| October 28, 2026 | 1.790M |
| October 27, 2026 | 1.774M |
| October 26, 2026 | 1.752M |
| October 23, 2026 | 1.725M |
| October 22, 2026 | 1.723M |
| October 21, 2026 | 1.698M |
| October 20, 2026 | 1.694M |
| October 19, 2026 | 1.692M |
| October 16, 2026 | 1.687M |
| Date | Value |
|---|---|
| October 15, 2026 | 1.665M |
| October 14, 2026 | 1.678M |
| October 13, 2026 | 1.655M |
| October 12, 2026 | 1.618M |
| October 09, 2026 | 1.609M |
| October 08, 2026 | 1.595M |
| October 07, 2026 | 1.558M |
| October 06, 2026 | 1.554M |
| October 05, 2026 | 1.499M |
| October 02, 2026 | 1.479M |
| October 01, 2026 | 1.447M |
| September 30, 2026 | 1.421M |
| September 29, 2026 | 1.407M |
| September 28, 2026 | 1.418M |
| September 25, 2026 | 1.396M |
| September 24, 2026 | 1.383M |
| September 23, 2026 | 1.372M |
| September 22, 2026 | 1.357M |
| September 21, 2026 | 1.347M |
| September 18, 2026 | 1.356M |
| September 17, 2026 | 1.312M |
| September 16, 2026 | 1.323M |
| September 15, 2026 | 1.347M |
| September 14, 2026 | 1.342M |
| September 11, 2026 | 1.355M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Mirum Pharmaceuticals, Inc. | 650419.2 |
| Regeneron Pharmaceuticals, Inc. | 910037.9 |
| AbbVie, Inc. | 5.258M |
| Alnylam Pharmaceuticals, Inc. | 2.712M |
| Insmed, Inc. | 3.708M |